FDA Cleared CHEMO as well just incase... And that has miserably failed///
There is absolutely NO CURE in NoVoCure!!
Best Short EVER IMO
This below statement from their PR confirms that fact!!
".....which has the Potential to meaningfully extend patient survival beyond what was previously possible.,& that says it all. |the Potential .. to extend ..Survival" ... Its all that she wrote~~~~
There is absolutely NO CURE in NoVoCure!!
Best Short EVER IMO
This below statement from their PR confirms that fact!!
".....which has the Potential to meaningfully extend patient survival beyond what was previously possible.,& that says it all. |the Potential .. to extend ..Survival" ... Its all that she wrote~~~~
Bearish
Recent NVCR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2026 08:00:26 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 09:01:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:01:40 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 11:01:01 AM
- Novocure Reports First Quarter 2026 Financial Results • Business Wire • 04/30/2026 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:08:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/20/2026 08:06:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/20/2026 08:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 09:04:13 PM
- Novocure to Report First Quarter 2026 Financial Results • Business Wire • 04/01/2026 11:00:00 AM
- Novocure shares gain on encouraging pancreatic cancer trial results • IH Market News • 03/26/2026 02:24:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:00:57 AM
- Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer • Business Wire • 03/26/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:33:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:31:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:06:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:54:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:53:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 10:42:44 PM
